Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
COVID-19 and psoriasis: biologic treatment and challenges
By
- AMS
posted
Jul 06, 2020 10:41 AM
0
Recommend
.
0 comments
0 views
Related Content
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
- AMS
Added Jun 19, 2020
Blog Entry
Epidermolysis bullosa and the COVID-19 pandemic: challenges and recommendations
- AMS
Added Jul 27, 2020
Blog Entry
Psoriasis and COVID-19: a multifactorial consideration
- AMS
Added Jun 22, 2020
Blog Entry
New evidence-based resources to guide treatment of plaque psoriasis
- AMS
Added Sep 08, 2021
Blog Entry
A survey of psoriasis patients on biologics during COVID-19: a single centre experience
- AMS
Added May 26, 2020
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic